Hussein Al-Mossawi

Company: Immunocore Ltd

Job title: Vice president of Immunology

Seminars:

Chair’s Opening Remarks 8:00 am

Read more

day: Day One

Pharma Icebreaker: Partnering & Innovation in Autoimmunity: Targets, Modalities & Next Generation Biologics 8:10 am

Exploring pharma’s evolving strategy across known targets, new modalities, and combination therapies to shape future partnering discussions Evaluating autoimmune cell therapy and next generation biologics to understand their capacity to drive future investments Uncovering key competitive differentiators prioritised in search and evaluation processes to drive deal-making and partnership decisionsRead more

day: Day One

Investor Icebreaker: When Being Selective, What Will Investors Choose? 11:30 am

Understanding venture focus across asset-centred investments and early-stage innovation to guide strategic investment discussions Discussing preferences for broad platforms or highly specific assets to understand asset maximization from a venture perspective Identifying exciting modalities, underestimated modalities and targets gaining traction in the global market to anticipate the next wave of autoimmune innovationRead more

day: Day One

Analyzing In Vivo Approaches, Delivery & Safety to Uncover their Future Potential 3:10 pm

Exploring the therapeutic potential of in vivo approaches, including in vivo and B-cell depletion to anticipate a future developments Assessing if the rules that govern cancer therapies are applicable to autoimmunity to effectively evaluate knockout strategies with lentiviral vectors or opportunities for redosing with mRNA Debating safety versus efficacy in the context of LNP and…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.